Fosaprepitant, sold under the brand names Emend (US) and Ivemend (EU) among others, is an antiemetic medication, administered intravenously. It is a prodrug of aprepitant.
{{Drugbox | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 416448532 | image = Fosaprepitant.svg | image_class = skin-invert-image | alt = Skeletal formula of fosaprepitant | width = 255 | image2 = Fosaprepitant-3D-spacefill.png | image_class2 = bg-transparent | alt2 = Space-filling model of the fosaprepitant molecule
| tradename = Emend, Ivemend | Drugs.com = | MedlinePlus = a604003 | licence_EU = yes | DailyMedID = Fosaprepitant | licence_US = Fosaprepitant | pregnancy_AU = B2 | pregnancy_AU_comment = | pregnancy_category = | routes_of_administration = Intravenous | ATC_prefix = A04 | ATC_suffix = AD12
Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).